The answer to this question may not be as straightforward as it seems
The syringe barrel presents a different surface than the vial (usually polypropylene versus borosilicate glass), and peptide adsorption to syringe surfaces can reduce potency
GLP-3 is being studied in people with obesity (BMI of 30 or higher) or those who are overweight (BMI of 27 or higher) with at least one weight-related health condition like high blood pressure, high cholesterol, or prediabetes
Key Risk: Amazon fails to drive meaningful patient volume/adherence (One Medical capacity, payer coverage, and fulfillment economics dont scale), leaving Lillys DTC economics intact
Due to on-and-off drug shortages, the FDA has also allowed state-licensed pharmacies, physicians, and outsourcing facilities to compound, dispense, and distribute compounded semaglutide that should be essentially a copy of FDA-approved semaglutide under sections 503A and 503B